Molecular Targets & Therapeutics

Ancient viral remnants embedded in the human genome may be an overlooked driver of Alzheimer’s disease. Dr. Michelle Vincendeau at Helmholtz Munich is investigating how so-called endogenous retroviruses influence disease-relevant mechanisms in human…

Healthy gut bacteria concept with natural probiotics for immune support.

Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. Led by researchers at Helmholtz Munich, with participation from Ludwig Maximilians University (LMU), Aix Marseille University, Inserm, and…

When Metabolism Meets Chromatin: Histone Acylations Tune Gene Expression

Metabolic dysfunction is a hallmark of numerous diseases, including diabetes and other metabolic disorders. But how do changes in our metabolism affect our cells and the way they function? How do they influence our genes?

Talented PhD students are encouraged to apply for the upcoming Chromatin Summer School taking place from 17 - 29 August 2026

Research into a novel form of cell death is entering its next phase and could soon help reduce complications after heart attacks or organ transplants. The Federal Ministry of Research, Technology, and Space (BMFTR) is providing continued support for…

Researchers at Helmholtz Munich, the Technical University of Munich and the LMU University Hospital Munich uncovered a mechanism that protects nerve cells from premature cell death, known as ferroptosis. The study provides the first molecular…

Molecular Targets & Therapeutics

News

Can Ancient Viral Remnants Trigger Alzheimer’s Disease?

More Than Just Gut Cohabitants: How Gut Bacteria Control Immune Responses

When Metabolism Meets Chromatin: Histone Acylations Tune Gene Expression

Empowering Young Scientists: Applications Open for 2026 Chromatin Summer School

Funding for Cell Death Research Extended

Single Enzyme Failure Found to Drive Neuron Loss in Dementia